Long Cast Advisers Q1 2026 Letter

1Q26 cumulative net returns were flat, roughly matching small- and micro-cap benchmarks including the Russell 2000 and microcap ETFs. Long Cast Advisers added to National Research Corporation and Cross Country Healthcare while exiting Richardson Electronics, Enovix, and CRAWA. Matrix Service Company reported a profitable quarter, and its ~$250M revenue guide implies fiscal 2026 EBITDA could reach about $15M, or roughly 7x EV/trailing EBITDA.

Analysis

The clearest signal here is not performance, but capital allocation within a depressed small-cap cohort: adding to NRC and CCRN while exiting RELL/ENVX implies a preference for businesses with near-term cash flow visibility over names where the market is still financing a promised future. That rotation matters because in weak tape environments, incremental demand tends to compress dispersion faster than it lifts the index, so “good enough” execution can re-rate materially while concept stocks continue to de-rate on every missed milestone.

MTRX looks like the most asymmetric setup. A move to roughly $15M of EBITDA against a 7x EV / trailing EBITDA multiple suggests the market is still anchoring to backward-looking earnings power; if guidance credibility holds, the more important catalyst is not the quarter itself but whether sell-side estimates reset fast enough over the next 1-2 reporting cycles. The second-order effect is that better pricing discipline in industrial services can attract generalist capital that has been waiting for proof of profitable growth, especially in a market segment where many peers remain structurally loss-making.

ENVX’s exit is a negative read on funding tolerance: if a holder with a small-cap lens is cutting a capital-intensive battery name, that often reflects concern that dilution risk can outrun technical progress for another 6-12 months. RELL’s exit is more subtle; even without a dramatic business deterioration, the stock can become a liquidity source when managers need to rotate into cleaner earnings streams, which tends to cap rallies in the absence of a hard catalyst. Overall, the consensus may be underestimating how much this quarter’s moves are about survival quality, not sector beta.

Key Decisions for Investors

• Long MTRX for 1-2 quarters on confirmation of guidance credibility; entry on any post-print weakness, target a re-rate toward 9-10x forward EBITDA, with downside contained if EBITDA holds near $15M.
• Pair long MTRX / short a low-quality industrial services peer with weaker margins and no profitability path; thesis is multiple spread expansion as capital rotates toward cash-generative small caps.
• Avoid or short ENVX on any rally over the next 3-6 months; the risk/reward remains skewed by financing overhang, and upside likely needs a broader sentiment regime shift rather than company-specific execution.
• Maintain a tactical long bias in NRC and CCRN only if upcoming quarters confirm operating leverage; use these as shorter-duration trades, since small-cap sentiment can reverse quickly if the market starts pricing in slower growth.
• Fade RELL strength into liquidity-driven spikes over the next 1-2 months; absent a new product or margin catalyst, the stock likely trades as a source of funds rather than a durable momentum name.